Therefore, taking IFI16 as the entry point to explore the mechanism of IFI16's involvement in p53 regulation of NF‐κB has clinical significance to further clarify the mechanism of cisplatin treatment of cervical cancer cells. This evidence concerns the gene NFKB1 and cervical carcinoma.